Intractable Pain clinical trials at UC Cancer
1 research study open to eligible people
Showing trials for
Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer
open to eligible people ages 18 years and up
This Phase 2 study assesses the safety and efficacy of a single injection of Resiniferatoxin versus placebo for the treatment of intractable advanced cancer pain.
Our lead scientists for Intractable Pain research studies include Joel Castellanos, MD.